VD2173
VD2173 is a side chain cyclized macrocyclic peptide inhibitor of HGF-activating serine proteases. VD2173 potently inhibits matriptase and hepsin. VD2173 can be used for the research of lung cancer[1].
Product Specifications
CAS Number
2574389-19-6
UNSPSC
12352005
Target
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vd2173.html
Solubility
10 mM in DMSO
Smiles
O=C1N[C@H](C(N[C@H](C(C2=NC3=CC=CC=C3S2)=O)CCCNC(N)=N)=O)CCCCNC(C[C@H](NC(C)=O)C(N[C@H]1CC(C)C)=O)=O
Molecular Formula
C31H45N9O6S
Molecular Weight
671.81
References & Citations
[1]Damalanka VC, et, al. Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression. J Med Chem. 2021 Dec 23;64 (24) :18158-18174.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1461331-01 0.02 mg (E-Coli)
Recombinant Rhizobium leguminosarum bv. viciae UDP-N-acetylmuramate--L-alanine ligase (murC)
Sign In for Pricing
View Details